Showing results (1931-1940 of 2,051) with videos related to
Sort By:
Pageof 206
Asiaintervention|March 21, 2025
Long-term safety and performance of the BioMime Morph sirolimus-eluting coronary stent system for very long coronary lesions in real-world settingsDeepak Davidson, Mukul Misra, Sharad Chandra, et al.The Lancet. Neurology|October 3, 2018
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trialScott E Kasner, Balakumar Swaminathan, Pablo Lavados, et al.Stroke|September 20, 2021
Frequency and Patterns of Brain Infarction in Patients With Embolic Stroke of Undetermined Source: NAVIGATE ESUS TrialMukul Sharma, Eric E Smith, Lesly A Pearce, et al.Circulation|January 23, 2019
Stroke Outcomes in the COMPASS TrialMukul Sharma, Robert G Hart, Stuart J Connolly, et al.JAMA Neurology|October 19, 2020
Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical TrialAshkan Shoamanesh, Robert G Hart, Stuart J Connolly, et al.Annals of Neurology|November 28, 2014
Early cerebral small vessel disease and brain volume, cognition, and gaitEric E Smith, Martin O'Donnell, Gilles Dagenais, et al.Journal of Clinical and Experimental Hepatology|July 19, 2021
Liver Transplantation Society of India Guidelines for the Management of Acute Liver Injury Secondary to Yellow Phosphorus-Containing Rodenticide Poisoning Using the Modified Delphi Technique of Consensus DevelopmentMettu S Reddy, Akila Rajakumar, Johns S Mathew, et al.The Lancet. Infectious Diseases|March 5, 2022
Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection studyBridget E Barber, Melissa Fernandez, Hardik Babubhai Patel, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 5, 2019
Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS TrialRobert G Hart, Roland C Veltkamp, Patrick Sheridan, et al.JAMA Neurology|July 7, 2020
Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical TrialRoland Veltkamp, Lesly A Pearce, Eleni Korompoki, et al.Pageof 206